Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

U.S. and India Planning to Develop Vaccines Through Public-Private Partnerships

Posted on September 30th, 2016 by in Pharma R&D

With the previous U.S. Secretary of State Hillary Clinton dominating news headlines these days due to her presidential bid, it’s easy to overlook the fact that America has a current Secretary of State hard at work. Continue reading “U.S. and India Planning to Develop Vaccines Through Public-Private Partnerships” »

Predictive Analytics for Drug Discovery

Posted on September 28th, 2016 by in Pharma R&D

The drive to predict molecular properties and thereby reduce lab testing and focus research projects started before the invention of the computer; a notable advance was with the Hammett equation in the 1930’s.[1]  Continue reading “Predictive Analytics for Drug Discovery” »

Venturing into the Microbiome

Posted on September 28th, 2016 by in Pharma R&D

The growing library of bacterial genomic material and microorganisms that reside within the human host is termed the microbiome. Microbiota, a less-used term, refers to the community of single cell organisms (i.e. bacteria, fungi, virus, etc.) that inhabit us, the superhost human organism. Prior to genomic sequencing, bacterial identification occurred by laboratory isolation and culturing. Continue reading “Venturing into the Microbiome” »

R&D Innovation & Pharma Drug-Device Pricing

Posted on September 26th, 2016 by in Pharma R&D

The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. Continue reading “R&D Innovation & Pharma Drug-Device Pricing” »

  1. 1
  2. 2
  3. 3
  4. 4